Hong Kong police investigate German firm claim it lost €3 million in email scam

[ad_1] “Last month, the company received an email purportedly sent out from the supplier, requesting a transfer of €3.16 million into a bank account in the mainland,” the insider said.…

Lupin shares hit 52-week high on strong Q2 results

[ad_1] Shares of pharmaceutical major Lupin surged as much as 2.18% to hit a 52-week high of ₹1,238.15 apiece on the BSE on Thursday, a day after the company reported…

Regulatory Review of Promotional Materials for an EU-based Pharmaceutical Company Across 60+ Global Markets

[ad_1] Discover how an EU-based pharmaceutical company navigated the complex world of regulatory compliance for promotional materials across 60+ global markets. This case study by IQVIA Regulatory Affairs highlights the…

Piramal Pharma shares rise 8% after Q2 results

[ad_1] Shares of Piramal Pharma rose as much as 8% to hit an intraday high of ₹100.30 apiece on the BSE after the company reported a consolidated net profit of…

Lupin acquires five brands from Italy’s Menarini to strengthen therapy portfolio

[ad_1] Pharmaceutical major Lupin has signed an agreement to acquire five legacy brands in strategic therapy areas—gastroenterology, urology and anti-infectives from Italy-based Menarini Group, according to the regulatory filing by…